Crewe Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Crewe Advisors's CRL Position: Q2 2026 in Review
Crewe Advisors opened a new position in Charles River Laboratories (CRL) in Q2 2026: 24 shares worth $5.44K. The stake represents ﹤0.01% of the portfolio and ranks #864 among its holdings. This is a return to the name: Crewe Advisors previously reported a position in CRL as recently as Q2 2024.
Crewe Advisors first reported a position in CRL in Q2 2022 and has held it in 4 quarters since. The position peaked at $9.92K in Q2 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Crewe Advisors held 24 shares of Charles River Laboratories worth $5.44K as of Q2 2026.
- Charles River Laboratories was a new Crewe Advisors position in Q2 2026.
- Charles River Laboratories made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #864 holding.
- Crewe Advisors first reported a position in Charles River Laboratories in Q2 2022 and has held it in 4 quarters since.
- Crewe Advisors's Charles River Laboratories position peaked at $9.92K in Q2 2024.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.